| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | -17.7% |
| Cost of Revenue | $2.3M | -14.9% |
| Gross Profit | $593K | -26.9% |
| R&D Expense | $318K | +97.6% |
| SG&A Expense | $18.9M | +51.4% |
| Operating Income | -$18.3M | -420.2% |
| Pre-tax Income | -$28.9M | -1265.8% |
| Income Tax | -$1.8M | -718.8% |
| Net Income | -$27.1M | -1022.4% |
| EPS (Basic) | -$0.92 | -70.4% |
| EPS (Diluted) | -$0.80 | -48.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | +2470.9% |
| Accounts Receivable | $319K | -64.7% |
| Inventory | $196K | -78.7% |
| Current Assets | $2.8M | +518.5% |
| Total Assets | $171.2M | +7335.3% |
| Current Liabilities | $17.2M | +155.5% |
| Long-term Debt | $498K | +0.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.3M | -97.8% |
| Investing Cash Flow | -$2.6M | -107.4% |
| Financing Cash Flow | $8.4M | +124.9% |
| $44.2M |
| +402.9% |
| Stockholders' Equity | $127.0M | +1624.4% |